Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
AlexVel AlexVel Pro
Sep 21, 2022 $36.89 -5.19% $37.64 V 98.01% 1
Sep 21, 2022 $37.25 -4.27% $37.64 V 98.96% 2
Sep 21, 2022 $29.93 -23.09% $37.64 V 79.50% 1
JS JS Pro
Sep 21, 2022 $37.62 -3.32% $37.64 V 99.95% 10
Sep 21, 2022 Bullish $37.64 V 0
AlexVel AlexVel Pro
Sep 13, 2022 $32.89 -1.47% $30.87 V 93.46% 1
JS JS Pro
Sep 13, 2022 $32.76 -1.86% $30.87 V 93.88% 1
Sep 13, 2022 Bullish $30.87 X 0
Rybkarybka Rybkarybka Merchant
Nov 1, 2021 $42.30 -8.26% $46.11 X 91.74% 0
JS JS Pro
Oct 28, 2021 $45.87 +3.17% $44.46 X 96.83% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE